Publications by authors named "Bo Dupont"

Claim this Profile
C
Cell-Extrinsic MHC Class I Molecule Engagement Augments Human NK Cell Education Programmed by Cell-Intrinsic MHC Class I.
Jeanette E Boudreau, Xiao-Rong Liu, Zeguo Zhao, Aaron Zhang, Leonard D Shultz, Bo Dupont

Immunity· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Donor activating KIR2DS1 in leukemia.
Jeffrey M Venstrom, Bo Dupont, Katharine C Hsu, Gianfranco Pittari, Ted A Gooley

N Engl J Med· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NK cell tolerance of self-specific activating receptor KIR2DS1 in individuals with cognate HLA-C2 ligand.
Gianfranco Pittari, Xiao-Rong Liu, Annamalai Selvakumar, Zeguo Zhao, Ernesto Merino, Bo Dupont

J Immunol· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment.
Nidale Tarek, Jean-Benoit Le Luduec, Meighan M Gallagher, Junting Zheng, Jeffrey M Venstrom, Bo Dupont

J Clin Invest· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1.
Jeffrey M Venstrom, Gianfranco Pittari, Ted A Gooley, Joseph H Chewning, Stephen Spellman, Bo Dupont

N Engl J Med· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Killer immunoglobulin-like receptor locus polymorphisms in multiple sclerosis.
Ilijas Jelcić, Katharine C Hsu, Kristina Kakalacheva, Petra Breiden, Bo Dupont

Mult Scler· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Donor activating KIR3DS1 is associated with decreased acute GVHD in unrelated allogeneic hematopoietic stem cell transplantation.
Jeffrey M Venstrom, Ted A Gooley, Stephen Spellman, James Pring, Mari Malkki, Bo Dupont

Blood· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KIR and HLA genotypes are associated with disease progression and survival following autologous hematopoietic stem cell transplantation for high-risk neuroblastoma.
Jeffrey M Venstrom, Junting Zheng, Nabila Noor, Karen E Danis, Alice W Yeh, Bo Dupont

Clin Cancer Res· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The lytic potential of human liver NK cells is restricted by their limited expression of inhibitory killer Ig-like receptors.
Bryan M Burt, George Plitas, Zeguo Zhao, Zubin M Bamboat, Hoang M Nguyen, Bo Dupont

J Immunol· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A panel of artificial APCs expressing prevalent HLA alleles permits generation of cytotoxic T cells specific for both dominant and subdominant viral epitopes for adoptive therapy.
Aisha N Hasan, Wouter J Kollen, Deepa Trivedi, Annamalai Selvakumar, Bo Dupont

J Immunol· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccination with recombinant NY-ESO-1 protein elicits immunodominant HLA-DR52b-restricted CD4+ T cell responses with a conserved T cell receptor repertoire.
Gilles Bioley, Christelle Dousset, Alice Yeh, Bo Dupont, Nina Bhardwaj

Clin Cancer Res· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HLA class I - associated immunodominance affects CTL responsiveness to an ESO recombinant protein tumor antigen vaccine.
Gilles Bioley, Philippe Guillaume, Immanuel Luescher, Alice Yeh, Bo Dupont

Clin Cancer Res· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infusion of haplo-identical killer immunoglobulin-like receptor ligand mismatched NK cells for relapsed myeloma in the setting of autologous stem cell transplantation.
Jumei Shi, Guido Tricot, Susann Szmania, Nancy Rosen, Tarun K Garg, Bo Dupont

Br J Haematol· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity study of NY-ESO-1b peptide and montanide ISA-51 vaccination of patients with epithelial ovarian cancer in high-risk first remission.
Catherine S M Diefenbach, Sacha Gnjatic, Paul Sabbatini, Carol Aghajanian, Martee L Hensley, Bo Dupont, Jakob Dupont

Clin Cancer Res· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HLA alleles determine differences in human natural killer cell responsiveness and potency.
Sungjin Kim, John B Sunwoo, Liping Yang, Taewoong Choi, Yun-Jeong Song, Bo Dupont

Proc Natl Acad Sci U S A· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KIR2DS1-positive NK cells mediate alloresponse against the C2 HLA-KIR ligand group in vitro.
Joseph H Chewning, Charlotte N Gudme, Katharine C Hsu, Annamalai Selvakumar, Bo Dupont

J Immunol· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy.
Katharine C Hsu, Ted Gooley, Mari Malkki, Clara Pinto-Agnello, Bo Dupont

Biol Blood Marrow Transplant· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry.
Sherif S Farag, Andrea Bacigalupo, Mary Eapen, Carolyn Hurley, Bo Dupont

Biol Blood Marrow Transplant· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic interaction among three genomic regions creates distinct contributions to early- and late-onset type 1 diabetes mellitus.
Eric I Felner, William Klitz, Melissa Ham, Ana M Lazaro, Peter Stastny, Bo Dupont

Pediatr Diabetes· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes.
Katharine C Hsu, Carolyn A Keever-Taylor, Andrew Wilton, Clara Pinto, Glenn Heller, Bo Dupont

Blood· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nomenclature for Factors of the HLA System, 2004.
Steven G E Marsh, Ekkehard D Albert, Walter F Bodmer, Ronald E Bontrop, Bo Dupont

Hum Immunol· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural killer cell receptors: regulating innate immune responses to hematologic malignancy.
Katharine C Hsu, Bo Dupont

Semin Hematol· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Wiskott-Aldrich syndrome protein regulates nuclear translocation of NFAT2 and NF-kappa B (RelA) independently of its role in filamentous actin polymerization and actin cytoskeletal rearrangement.
Winifred Huang, Hans D Ochs, Bo Dupont, Yatin M Vyas

J Immunol· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibitory killer Ig-like receptor genes and human leukocyte antigen class I ligands in haematopoietic stem cell transplantation.
Bo Dupont, Katharine C Hsu

Curr Opin Immunol· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Ligand binding to inhibitory killer cell Ig-like receptors induce colocalization with Src homology domain 2-containing protein tyrosine phosphatase 1 and interruption of ongoing activation signals.
Yatin M Vyas, Hina Maniar, Clay E Lyddane, Michel Sadelain, Bo Dupont

J Immunol· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis